article thumbnail

COVID-19 Showcased Failed Global Cooperation

Bill of Health

Global solidarity requires cooperation between governments, while national solidarity involves cooperation within a state to address common challenges and achieve shared goals. Solidarity operates at two intersecting levels. That has created deep inequities in access to health products that can save lives.

COVID-19 303
article thumbnail

The European Commission’s New Compulsory Licensing Proposal: A Step Forward?

Bill of Health

When there is a compulsory license in place, a government of a country allows a third party to manufacture and distribute a product protected by patents, without the consent of the patent owner. The Proposal A compulsory license allows third parties to use a patent without asking prior permission from the owner of said patent.

Licensing 291
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The Gains and Pains of Using AI in the Pharmaceutical Industry

HIT Consultant

In addition to these challenges specific to their industry, pharma companies are all also presented with classic barriers to implementation. For example, the need for a flexible infrastructure to collect data, verify data, run applications, and perform data governance.

article thumbnail

Streamlining Compliance in the Pharmaceutical Industry with the eQMS

Dot Compliance

In the pharmaceutical industry, the importance of regulatory compliance extends beyond fulfilling legal obligations. Compliance can be streamlined with the help of an electronic quality management system (eQMS) that incorporates regulatory standards into every operational aspect of a pharmaceutical organization.

article thumbnail

No Take-Backs: Moderna’s Attempt to Renege on its Vaccine Patent Pledge

Bill of Health

government funding, announced that it felt “a special obligation … to use our resources to bring this pandemic to an end as quickly as possible.” government purchased millions of doses of Moderna’s mRNA vaccine, along with large quantities of vaccines manufactured by Pfizer. By Jorge L. Updating” the Pledge. From 2020 to 2022, the U.S.

article thumbnail

California Enters Insulin Manufacturing: Can We Expect to See a California Effect?

Bill of Health

By Aparajita Lath For over 100 years, policy makers and pharmaceutical manufacturers in the U.S. have debated whether the government should produce drugs and biologics. Until now, private industry has largely won– but that may be changing, due to a recent California initiative. Now, the tide is turning.

article thumbnail

The Case for Procurement Transparency

Bill of Health

Global health activists and civil society organizations who worked transnationally to curtail what came to be referred to as “vaccine apartheid” faced a pharmaceutical industry that globally relied on secrecy, capital-friendly trade laws, and brute economic force to shirk considerations of human rights.